19/05/2020
To help in the fight against Covid-19, Fabric Solutions Australia has successfully negotiated an agreement to manufacture under license a non-invasive ventilator hood system from Subsalve (USA), (https://www.subsalve.com/helmet ).
Fabric Solutions Australia has appointed FloatPac Pty Ltd (https://www.floatpac.com/flexitank/oxygen-treatment-hoods), a long-standing strategic partner, as the exclusive sales and marketing entity for the hood.
The oxygen hood can also be used in the treatment of other respiratory diseases and illnesses and is primarily used as a non-invasive positive pressure ventilation (NIPPV) in the treatment of acute respiratory distress syndrome (ARDS). More information about ARDS can be found at https://www.mayoclinic.org/diseases-conditions/ards/symptoms-causes/syc-20355576
Why Non-Invasive Ventilators?
Covid-19 patients who experience respiratory distress will more than likely require intubation or some ventilation support. As face masks are not recommended for use with Covid-19 patients, due to the risk of aerosolisation of the virus, a patient would typically then be intubated (as of March 2020 in the USA, https://www.uchicagomedicine.org/forefront/coronavirus-disease-covid-19/uchicago-medicine-doctors-see-truly-remarkable-success-using-ventilator-alternatives-to-treat-covid19 ). Outcomes for intubated patients in many countries have suggested a higher mortality rate (see for example https://www.rtmagazine.com/disorders-diseases/critical-care/icu-ventilation/early-data-on-ventilated-covid-19-patients-reveals-severe-mortality/ or ). Contrast these outcomes to countries like Italy, who have been using non-invasive ventilation for decades as an intermediate step for managing patients. The use of oxygen hoods has shown a 25 to 40% reduction(https://www.uchicagomedicine.org/forefront/coronavirus-disease-covid-19/uchicago-medicine-doctors-see-truly-remarkable-success-using-ventilator-alternatives-to-treat-covid19 and https://www.uchicagomedicine.org/forefront/patient-care-articles/helmet-based-ventilation-is-superior-to-face-mask-for-patients-with-respiratory-distress) in the need for invasive ventilation, thus reducing mortality rates and improving patient outcomes.
Because the Covid-19 crisis has seen unprecedented demand for these types of ventilators, Fabric Solutions Australia has aligned with Floatpac and signed an agency agreement with Subsalve to meet this much needed demand. Subsalve’s design was in direct response to the Covid-19 crisis and they have drawn heavily on their experience with face masks in deep sea diving.
Oxygen Treatment Standard Applications
There are primarily two standard applications which our non-invasive ventilation hood can be used for.
1 - Oxygen treatment hood interfaced with a hospital wall system
2 - Oxygen treatment hood interfaced with a mechanical ventilator and BiPAP V60
We will upload more details about this new product shortly to our website.